Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Catalyst Pharmaceuticals Stock (NASDAQ: CPRX) stock price, news, charts, stock research, profile.
Open | $20.99 |
Close | - |
Volume / Avg. | 187.48K / 1.15M |
Day Range | $20.46 - $20.99 |
52 Wk Range | 11.55 - 21.67 |
Market Cap | $2.44B |
P/E Ratio | 37.11 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 6.04% |
Days to Cover | 6.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Catalyst Pharmaceuticals (NASDAQ:CPRX) through any online brokerage.
Other companies in Catalyst Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
Catalyst Pharmaceuticals has a consensus price target of $26.56.
The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $20.56 last updated September 23, 2024 at 11:31 AM EDT.
There are no upcoming dividends for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.